Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Erdafitinib | 1346242-81-6 | sc-507388 | 10 mg | $138.00 | ||
Erdafitinib is an inhibitor of FRS2 and other fibroblast growth factor receptors. | ||||||
BGJ398 | 872511-34-7 | sc-364430 sc-364430A sc-364430B sc-364430C | 5 mg 10 mg 50 mg 100 mg | $212.00 $247.00 $582.00 $989.00 | 4 | |
BGJ398 is an inhibitor of multiple fibroblast growth factor receptors, including FRSIt has been investigated for its potential in various cancers, including gastric, bladder, and lung cancers. | ||||||
Dovitinib, Free Base | 405169-16-6 | sc-396771 sc-396771A | 10 mg 25 mg | $170.00 $350.00 | ||
Dovitinib is a multikinase inhibitor that targets FRS2 along with other receptor tyrosine kinases. It has been evaluated in laboratory settings for its efficacy in various cancers. | ||||||
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
AZD4547 is an experimental FRS2 inhibitor that has been investigated for its potential in various cancers, particularly those with aberrant fibroblast growth factor receptor signaling. | ||||||
Debio-1347 | 1265229-25-1 | sc-507386 | 10 mg | $324.00 | ||
Debio-1347 is an investigational FRS2 inhibitor that has shown activity against cancers with FRS2 alterations. |